Cyclophosphamide levels in serum and spinal fluid of multiple sclerosis patients treated with immunosuppression.
The cyclophosphamide content of urine, serum and spinal fluid of immuno-suppressed multiple sclerosis patients was determined using a newly developed off-line combination of high pressure liquid chromatography and field desorption mass spectrometry. Although urinary excretion of the drug varied considerably between patients, the levels in serum and spinal fluid were in the same range, a relationship that may facilitate control of the dosage.
D000328:Adult; D001812:Blood-Brain Barrier / Q000187:drug effects; D003520:Cyclophosphamide / Q000378:metabolism* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007165:Immunosuppression Therapy; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism*; D011241:Prednisone / Q000627:therapeutic use
D007074:Immunoglobulin G; D003520:Cyclophosphamide; D011241:Prednisone